For investment teams, lenders and corporate decision-makers following India. Kiwaro Notes connects consequential developments to revenue, costs, cash flow and the next decision.
Discuss institutional accessGo beyond the event to examine how a rule, market change or company disclosure travels through a business.
Read the source attribution, follow the underlying documents and distinguish reported facts from analytical interpretation.
Each analysis identifies the further evidence that could change the conclusion, so a developing issue stays useful beyond its first headline.
Discuss coverage priorities, team access and subscription requirements.
The government's one-year rate is the highest since 2 April 2025. Listed companies booked ₹3.5 lakh crore of interest in the four quarters to June, no less than a year earlier despite 1.25 points of rate cuts, and power companies' burden rose. The Reserve Bank of India decides on 7 October.
KIMS's pharmacy income is at least 48% above the cost of every drug and consumable it used. None of the other eight chains examined shows separately what it bills admitted patients for medicines. The next hearing is on 12 October.
Comments close on 3 October. BSE's daily options turnover was about 26% lower in August, the first month of the new closing auction, than in July. One option adopts a blended settlement price immediately; the other permits a later move if liquidity is sufficient.
